F. Pepedil Et Al. , "What if a hypertensive patient taking losartan has genetic polymorphism of cyp2c9?," ESC Congress , vol.31, Stockholm, Sweden, pp.692, 2010
Pepedil, F. Et Al. 2010. What if a hypertensive patient taking losartan has genetic polymorphism of cyp2c9?. ESC Congress , (Stockholm, Sweden), 692.
Pepedil, F., Goktas, M., Tulumen, E., Evranos, B., Yasar, U., Babaoglu, M. O., ... Cakir, B.(2010). What if a hypertensive patient taking losartan has genetic polymorphism of cyp2c9? . ESC Congress (pp.692). Stockholm, Sweden
Pepedil, F. Et Al. "What if a hypertensive patient taking losartan has genetic polymorphism of cyp2c9?," ESC Congress, Stockholm, Sweden, 2010
Pepedil, F. Et Al. "What if a hypertensive patient taking losartan has genetic polymorphism of cyp2c9?." ESC Congress , Stockholm, Sweden, pp.692, 2010
Pepedil, F. Et Al. (2010) . "What if a hypertensive patient taking losartan has genetic polymorphism of cyp2c9?." ESC Congress , Stockholm, Sweden, p.692.
@conferencepaper{conferencepaper, author={F. Pepedil Et Al. }, title={What if a hypertensive patient taking losartan has genetic polymorphism of cyp2c9?}, congress name={ESC Congress}, city={Stockholm}, country={Sweden}, year={2010}, pages={692} }